Viyash Scientific Limited
All news and filings related to Viyash Scientific Limited.
View all news & filings- Low impact
Viyash Scientific Allots 1,13,001 Equity Shares Under ESOP 2020
Viyash Scientific Limited allotted 1,13,001 equity shares under its ESOP 2020 plan. The exercise price was Rs. 86 per share. This increases the company's paid-up capital to Rs. 87,34,61,620.
Read the summary - Low impact
Viyash Scientific Announces Newspaper Publication for Postal Ballot Dispatch
Viyash Scientific Limited has confirmed the dispatch of its Notice of Postal Ballot via newspaper advertisements on February 11, 2026. This action aligns with SEBI regulations. The company is also managing legal matters and regulatory compliance.
Read the summary - Medium impact
Viyash Scientific Ltd. Seeks Shareholder Approval for Key Appointments via Postal Ballot
Viyash Scientific is seeking shareholder approval via postal ballot for key appointments and stock options. This includes appointing Dr. Haribabu Bodepudi as MD & Group CEO and Mr. Srinivas Vasireddy as Whole-time Director (Executive) for two years. Mr. Rajaram Narayanan will be appointed Whole-time Director and CEO – Animal Health Business. E-voting runs from Feb 11 to Mar 12, 2026.
Read the summary - Medium impact
Viyash Scientific Q3 FY26 Earnings Call Transcript Released
Viyash Scientific reported Q3 FY26 revenue of ₹858 crore, up 11% YoY, with Adjusted EBITDA at ₹185 crore, up 64% and margins at 21%. For 9M FY26, revenue reached ₹2,500 crore (up 12%) and EBITDA was over ₹500 crore (up 58%). The company is confident in sustaining 20% EBITDA margins and achieving FY27 targets earlier than planned.
Read the summary - Medium impact
Viyash Scientific Publishes Q3FY26 Unaudited Financial Results
Viyash Scientific Limited published its unaudited financial results for Q3FY26. The company is undertaking significant capital expenditure, including a new ₹200 crore API manufacturing facility in Hyderabad, a ₹200 crore unit in Visakhapatnam, and a ₹120 crore project in Gujarat. These projects are expected to be completed between March 2026 and March 2027.
Read the summary - Low impact
Viyash Scientific releases audio recording of earnings call for Q3 FY26 results.
Viyash Scientific Limited has released the audio recording of its earnings call for the quarter and nine months ended December 31, 2025. The call took place on February 06, 2026. The recording is available on the company's website.
Read the summary - High impact
Viyash Scientific Q3 FY26 Revenue ₹858.4 Cr, EBITDA ₹185.4 Cr, up 10.9% & 64.4%
Viyash Scientific reported Q3 FY26 revenues of ₹858.4 crore, up 10.9%, and EBITDA of ₹185.4 crore, up 64.4%. For 9M FY26, revenues increased by 11.9% to ₹2,500.4 crore, with EBITDA up 58% to ₹502.4 crore. PAT for 9M FY26 surged by 230%. Net Debt/EBITDA ratio is 0.38x.
Read the summary - High impact
Viyash Scientific announces Q3 FY26 results, approves new ESOP scheme, and management changes
Viyash Scientific Limited reported Q3 FY26 results with consolidated revenue at ₹8,584.10 crore and profit before tax at ₹1,143.30 crore. The company approved the Viyash Scientific Limited Employee Stock Option Scheme 2026, with up to 1,34,75,000 stock options. Changes in Senior Management Personnel were also approved, including the appointment of Mr. Attanti Veera Venkata Srinivasa Rao and others.
Read the summary - Medium impact
Viyash Scientific Approves Q3 FY26 Results & New ESOP Scheme
Viyash Scientific Limited reported its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company also approved the "Viyash Scientific Limited Employee Stock Option Scheme 2026", which may result in the issuance of up to 1,34,75,000 stock options. Additionally, changes in Senior Management Personnel were approved.
Read the summary - Low impact
Viyash Scientific Reschedules Q3FY26 Earnings Call to Feb 06
Viyash Scientific Limited has rescheduled its Q3FY26 earnings conference call to Friday, February 06, 2026, at 5:30 PM IST. The call will feature the Managing Director & Group CEO, CEO of Animal Health, and CFO.
Read the summary - Low impact
Viyash Scientific Allots 4,83,333 Shares Under ESOP 2020 at ₹86/Share
Viyash Scientific Limited approved the allotment of 4,83,333 equity shares under its ESOP 2020. The shares were issued at an exercise price of Rs. 86 per share. This increases the company's paid-up equity share capital to Rs. 87,32,35,618.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio